CMC announces $212M net earnings for fourth quarter
CMC (NYSE:CMC) reported fiscal fourth-quarter net earnings of $212.5 million as sales expanded 25.7% year-over-year to $2.66 billion on strong North American demand.
Every story in this section, newest first — page 25 of 372.
CMC (NYSE:CMC) reported fiscal fourth-quarter net earnings of $212.5 million as sales expanded 25.7% year-over-year to $2.66 billion on strong North American demand.
The Bank of New York Mellon Corp. (NYSE:BK) reported third-quarter 2026 total revenue of $5.68 billion, growing 11.7% year-over-year and beating consensus analyst estimates.
Surf Air Mobility (NYSE:SRFM) signed a definitive agreement with Flying Zebra for its Palantir Technologies (NASDAQ:PLTR) powered OperatorOS software, marking its fifth commercial software contract.
PNC Financial Services Group (NYSE:PNC) reported third-quarter 2026 net income of $2.1 billion, supported by an 11% year-over-year revenue increase.
First Horizon Corporation (NYSE:FHN) reported a third-quarter 2026 net loss available to common shareholders of $94 million, or $0.20 per diluted share.
Venture Global (NYSE:VG) entered into power frame agreements with GE Vernova and Baker Hughes for up to 16 power island units to support 10 gigawatts of new capacity.
Beam Global (NASDAQ:BEEM) announced that its pending acquisition target, ScoutDI, received an order for drone inspection systems from a nuclear-sector customer.
Organigram Global (NASDAQ:OGI) completed its integration of Sanity Group GmbH while targeting up to $10 million in annualized cost savings.
TSMC (NYSE:TSM) has entered into discussions regarding potential collaboration on Elon Musk's Terafab project while maintaining that it must operate any semiconductor plant in an alliance.
Taiwanese President Lai Ching-te called on Micron Technology (NASDAQ:MU) and its workers to negotiate sincerely following union authorization for potential strike action over a bonus scheme dispute.
Brent Crude futures fell 1.7% to $104.30 a barrel on Thursday as potential US sanction relief offset escalating supply risks in the Strait of Hormuz.
Gibraltar Industries (NASDAQ:ROCK) has agreed to sell its infrastructure business, D.S. Brown, to Saint-Gobain for $208 million in cash.
Taiwan Semiconductor Manufacturing Company (NYSE:TSM) reported a record third-quarter net profit of NT$763.06 billion ($23.55 billion), driven by sustained global demand for artificial intelligence chips.
Winmark Corporation (NASDAQ:WINA) reported net income of $11.8 million, or $3.21 per diluted share, for the quarter ended September 26, 2026.
Apple (NASDAQ:AAPL) has asked a federal judge in San Diego to overturn a $5.7 billion patent verdict won by Taction Technology over haptic feedback technology used in Apple’s iPhones and Apple Watches.
AmpliTech Group (NASDAQ:AMPG) announced that it secured over $17 million in customer purchase orders during the quarter ended September 30, 2026.
Netflix (NASDAQ:NFLX) has officially announced a workforce reduction of approximately 1,000 employees, representing about 6% of its global workforce.
Fluence Energy (NASDAQ:FLNC) signed an agreement with Vattenfall to deliver the planned Brunsbüttel battery storage facility and provide long-term service support.
The Progressive Corporation (NYSE:PGR) reported third-quarter 2026 financial results, with earnings per share of $4.37 compared with analyst expectations of $4.42.
Sarepta Therapeutics (NASDAQ:SRPT) presented new preclinical findings from its SRP-1003 program at the 22nd Annual Meeting of the Oligonucleotide Therapeutics Society (OTS).
Viking Therapeutics (NASDAQ:VKTX) announced the start of its SUNRISE Phase 3 clinical program for oral VK2735, an investigational therapy being developed for obesity management.
Alpha Compute (NASDAQ:ALP) announced that it entered into a binding GPU compute services agreement on October 9, 2026, for its first contracted U.S. GPU cluster.
Parabilis Medicines (NASDAQ:PBLS) announced the initiation of a new dose-ranging cohort for zolucatetide in adults with familial adenomatous polyposis, a hereditary condition associated with the development of precancerous polyps.
Takeda Pharmaceutical (NYSE:TAK) presented new data from the pivotal Phase 2/3 IgGNITE clinical trial (TAK-881-3001) evaluating TAK-881 Immune Globulin Subcutaneous (Human), 20% Solution combined with recombinant human hyaluronidase.
Got a second for a cookie? 🍪Essential cookies keep Grafa running smoothly. A few optional ones help us see what's working so we can make it better. You're in control — change your mind any time. Cookie policy · Privacy policy